Scinai Immunotherapeutics (SCNI) Retained Earnings (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Scinai Immunotherapeutics (SCNI) has disclosed Retained Earnings for 2 consecutive years, with -$125.8 million as the latest value for Q4 2025.

• Quarterly Retained Earnings fell 7132.53% to -$125.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$125.8 million through Dec 2025, down 7132.53% year-over-year, with the annual reading at -$125.8 million for FY2025, 7132.53% down from the prior year.
• Retained Earnings hit -$125.8 million in Q4 2025 for Scinai Immunotherapeutics, down from -$1.7 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$1.7 million in Q4 2024 to a low of -$125.8 million in Q4 2025.

Peer Comparison